Advertisement

European Journal of Clinical Pharmacology

, Volume 70, Issue 7, pp 799–815 | Cite as

Application of drug-related problem (DRP) classification systems: a review of the literature

  • Benjamin J. BasgerEmail author
  • Rebekah J. Moles
  • Timothy F. Chen
Review Article

Abstract

Background

For over 20 years, researchers wanting to record, discuss and compare drug-related problems (DRPs) have had the task of choosing between a multiplicity of classification systems offering a variable number of categories identified as causes of DRPs and DRPs.

Objective

To characterise studies which have reported DRPs through the use of a DRP classification system to determine types of classification systems chosen, factors influencing their choice, and methodological issues that may have affected their application.

Method

A systematic search of MEDLINE, CINAHL, International Pharmaceutical Abstracts (Ovid), EMBASE and PubMed was performed. All English language studies reporting DRPs through the use of a classification system published between January 2000 and July 2013 were reviewed, with no limitation on the type of study.

Results

Of 2,774 articles screened, 268 met our inclusion criteria. We identified the use of 20 different types of DRP classification systems. Three quarters of studies modified an existing classification system or developed their own. Few studies stated reasons for choice of system. We identified issues such as variability in skills of data collectors, selective choice of patients and missing data, affecting application of classification systems and limiting quality, analysis and comparison of studies.

Conclusion

There appeared to be no consensus on preference or structure of classification systems. Future studies should consider addressing or acknowledging the methodological issues identified. Through identification and discussion of these problems, recommendations for future studies and for practice have been made.

Keywords

Drug-related problems Drug therapy problems Medicine-related problems Therapy-related problems Medication-related problems Drug management problems Classification system 

Notes

Conflict of interest

All authors declare that we have no conflict of interest. The manuscript does not contain clinical studies or patient data, for which consent or ethical permission was required.

Supplementary material

228_2014_1686_MOESM1_ESM.docx (14 kb)
ESM 1 (DOCX 13 kb)
228_2014_1686_MOESM2_ESM.docx (256 kb)
ESM 2 (DOCX 255 kb)

References

  1. 1.
    Hepler CD, Strand LM (1990) Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533–543PubMedGoogle Scholar
  2. 2.
    Van Mil JWF, Westerlund T, Hersberger T, Schaefer MA (2004) Drug-related problem classification systems. Ann Pharmacother 38:859–867PubMedGoogle Scholar
  3. 3.
    Comite de Consenso (2007) Third consensus of Grenada on drug related problems (DRP) and negative outcomes associated with medicines http://farmacia.ugr.es/ars/pdf/374.pdf Accessed 5 March 2014
  4. 4.
    Fernandez-Llamazares CM, Manrique-Rodriguez S, Perez-Sanz C, Duran-Garcia ME, Sanjurjo-Saez M, Calleja-Hernandez MA (2012) Validation of a method for recording pharmaceutical interventions. J Clin Pharm Ther 37:459–463PubMedGoogle Scholar
  5. 5.
    Cipolle RJ, Strand LM, Morley PC (1998) Pharmaceutical care practice. McGraw-Hill, New YorkGoogle Scholar
  6. 6.
    Baena MI, Faus MJ, Fajardo PC, Luque FM, Sierra F, Martinez-Olmos J, Cabrera A, Fernandez-Llimos F, Martinez-Martinez F, Jimenez J, Zarzuelo A (2006) Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol 62:387–393PubMedGoogle Scholar
  7. 7.
    Bondesson A, Eriksson T, Kragh A, Holmdahl L, Midlov P, Hoglund P (2013) In-hospital medication reviews reduce unidentified drug-related problems. Eur J Clin Pharmacol 69:647–655PubMedGoogle Scholar
  8. 8.
    Gomez MA, Villafaina A, Hernandez J, Salgado RM, Gonzalez MA, Rodriguez J, de la Concha MM, Tarrino A, Gervasini G, Carrillo JA (2009) Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting. Ann Pharmacother 43:339–346PubMedGoogle Scholar
  9. 9.
    Krska J, Jamieson D, Arris F, McGuire AJ, Abbott S, Hansford D, Cromarty JA (2002) A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 10:91–100Google Scholar
  10. 10.
    Lampert ML, Kraehenbuehl S, Hug BL (2008) Drug-related problems: evaluation of a classification system in the daily practice of a Swiss university hospital. Pharm World Sci 30:768–776PubMedGoogle Scholar
  11. 11.
    MacKinnon NJ, Morais CL, Rose T (2007) Drug-related problems identified in a workplace asthma self-management program. Can Pharm J 140:110–115Google Scholar
  12. 12.
    Vinks THAM, de Koning FHP, de Lange TM, Egberts TCG (2006) Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 28:33–38PubMedGoogle Scholar
  13. 13.
    Ruths S, Viktil KK, Blix HS (2007) Classification of drug-related problems. Tidsskr Nor Laegeforen 127:3073–3076PubMedGoogle Scholar
  14. 14.
    AbuRuz SM, Bulatova NR, Yousef AM (2006) Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci 28:222–232PubMedGoogle Scholar
  15. 15.
    Al-Arifi M, Abu-Hashem H, Al-Meziny M, Said R, Aljadhey H (2013) Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia. Saudi Med J. doi: 10.1016/j.jsps.2013.01.001 Google Scholar
  16. 16.
    Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R (2012) Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm 34:828–831PubMedGoogle Scholar
  17. 17.
    Leendertse AJ, de Koning FHP, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts ACG, van den Bemt PMLA (2013) Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther 38:379–387PubMedGoogle Scholar
  18. 18.
    Nicolas A, Eickhoff C, Griese N, Schulz M (2013) Drug-related problems in prescribed medicines in Germany at the time of dispensing. Int J Clin Pharm 35:476–482PubMedGoogle Scholar
  19. 19.
    Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H (2004) Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 26:353–360PubMedGoogle Scholar
  20. 20.
    Williams M, Peterson GM, Tenni PC, Bindoff IK, Curtain C, Hughes J, Bereznicki LRE, Jackson SL, Kong DCM, Hughes JD (2011) Drug-related problems detected in Australian Community Pharmacies: The PROMISe trial. Ann Pharmacother 45:1067–1076PubMedGoogle Scholar
  21. 21.
    Young SW, Bishop LD, Conway A (2012) Interventions performed by community pharmacists in one Canadian province: a cross-sectional study. Ther Clin Risk Manag 8:415–421PubMedCentralPubMedGoogle Scholar
  22. 22.
    Farrell B, Szeto W, Shamji S (2011) Drug-related problems in the frail elderly. Can Fam Physician 57:168–169PubMedCentralPubMedGoogle Scholar
  23. 23.
    Halvorsen KH, Ruths S, Granas AG, Viktil KK (2010) Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care 28:82–88PubMedCentralPubMedGoogle Scholar
  24. 24.
    Huri HZ, Wee HF (2013) Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. www.biomedcentral.com/1472-6823/13/2. BMC Endocrine Disorders 13:1–12
  25. 25.
    Chan D-C, Chen J-H, Kuo H-K, We C-J, Lu I-S, Chiu L-S, Wu S-C (2012) Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr 54:168–174PubMedGoogle Scholar
  26. 26.
    Christensen AB, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T (2011) The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm 33:1010–1018Google Scholar
  27. 27.
    Eichenberger PM, Lampert ML, Kahmann IV, van Mil JWF, Hersberger KE (2010) Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci 33:362–372Google Scholar
  28. 28.
    Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC (2012) DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm 34:43–52PubMedGoogle Scholar
  29. 29.
    Gordon KJ, Smith FJ, Dhillon S (2005) The development and validation of a screening tool for the identification of patients experiencing medication-related problems. Int J Pharm Pract 13:187–193Google Scholar
  30. 30.
    Haley M, Raymond C, Nishi C, Bohm E (2009) Drug-related problems in patients undergoing elective total joint arthroplasty of the hip or knee. Can J Hosp Pharm 62:360–366PubMedCentralPubMedGoogle Scholar
  31. 31.
    Hammerlein A, Griese N, Schulz M (2007) Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 41:1825–1832PubMedGoogle Scholar
  32. 32.
    Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C (2006) Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother 40:720–728PubMedGoogle Scholar
  33. 33.
    Zargarzadeh AH, Emami MH, Hosseini F (2007) Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 34:494–498PubMedGoogle Scholar
  34. 34.
    Bjorkman IK, Bernsten CB, Sanner MA (2008) Care ideologies reflected in 4 conceptions of pharmaceutical care. Res Soc Adm Pharm 4:332–342Google Scholar
  35. 35.
    Bjorkman IK, Sanner MA, Bernsten CB (2008) Comparing 4 classification systems for drug-related problems: processes and functions. Res Soc Adm Pharm 4:320–331Google Scholar
  36. 36.
    Crisp GD, Burkhart JI, Esserman DA, Weinberger M, Roth MT (2011) Development and testing of a tool for assessing and resolving medication-related problems in older adults in an ambulatory care setting: the individualised medication assessment and planning (iMAP) tool. Am J Geriatr Pharmacother 9(6):451–460PubMedCentralPubMedGoogle Scholar
  37. 37.
    Fernandez-Llimos F, Tuneu L, Baena MI, Garcia-Delgado A, Faus MJ (2004) Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems. Curr Pharm Des 10:3947–3967PubMedGoogle Scholar
  38. 38.
    Pharmaceutical Care Network Europe Foundation (2010) Classification for drug related problems V6.2 http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf. Accessed 10 Jan 2014
  39. 39.
    Cipolle RJ, Strand LM, Morley PC (2012) Pharmaceutical care practice: the patient centered approach to medication management Services, 3rd edn. McGraw-Hill, New YorkGoogle Scholar
  40. 40.
    Westerlund TLO, Bjork HT (2006) Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 40:1162–1169PubMedGoogle Scholar
  41. 41.
    Burns A (2008) Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 48:341–353Google Scholar
  42. 42.
    Pharmaceutical Society of Australia (2011) Guidelines for pharmacists providing Home Medicines Review (HMR) services 2011 http://www.psa.org.au/download/practice-guidelines/home-medicines-review-services.pdf. Accessed 3 March 2014
  43. 43.
    Peterson G, Tenni PC, Bereznicki L, Hughes J, Kong D, Doran C, Williams M, Curtain C, Hughes J, Ellerton L, Bindoff I (2010) PROMISe III: Documenting clinical interventions in community pharmacy. http://guild.org.au/services-programs/research-and-development/archive---fourth-agreement/2007-08-09. Accessed 28 Jan 2014
  44. 44.
    Taylor G (2013) SHPA standards of practice for clinical pharmacy services. Society of Hospital Pharmacists of Australia. J Pharm Pract Res 43:S1–S62Google Scholar
  45. 45.
    Dutch College of General Practitioners (2012) Multidisciplinary directive polypharmacy in the elderly https://www.nhg.org/themas/artikelen/mdr-polyfarmacie-bij-ouderen. Accessed 3 Mar 2014
  46. 46.
    Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535PubMedCentralPubMedGoogle Scholar
  47. 47.
    Sollaci LB, Periera MG (2004) The introduction, methods, results, and discussion (IMRAD) structure: a fifty-year survey. J Med Libr Assoc 92:364–371PubMedCentralPubMedGoogle Scholar
  48. 48.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724PubMedGoogle Scholar
  49. 49.
    National Health and Medical Research Council (2000) How to use the evidence: assessment and application of scientific evidence. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp69.pdf. Accessed 3 Mar 2014
  50. 50.
    AbuRuz SM, Bulatova NR, Yousef AM, Al-Ghazawi AM, Alawwa IA, Al-Saleh A (2011) Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. Int J Clin Pharm 33:501–511PubMedGoogle Scholar
  51. 51.
    Andersson AC, Brodin H, Nilsson JLG (2003) Pharmacist interventions in relation to patient drug-related problems. J Soc Adm Pharm 20:82–91Google Scholar
  52. 52.
    Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ (2009) Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 15:18–31PubMedGoogle Scholar
  53. 53.
    Bedouch P, Allenet B, Grass A, Labarere J, Brudieu E, Bosson J-L, Calop J (2009) Drug-related problems in medical wards with a computerised physician order entry system. J Clin Pharm Ther 34:187–195PubMedGoogle Scholar
  54. 54.
    Bergqvist M, Ulfvarson J, Karlsson EA, Von Bahr C (2008) A nurse-led intervention for identification of drug-related problems. Eur J Clin Pharmacol 64:451–456PubMedGoogle Scholar
  55. 55.
    Blakey SA, Hixson-Wallace JA (2000) Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic. Pharmacotherapy 20:1198–1203PubMedGoogle Scholar
  56. 56.
    Bulsink A, Imholz ALT, Brouwers JRBJ, Jansman FGA (2013) Characteristics of potential drug-related problems among oncology patients. Int J Clin Pharm 35:401–407PubMedGoogle Scholar
  57. 57.
    Dhabali AAH, Awang R, Hamdan Z, Zyoud SH (2012) Association between the prescribing of non-steroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting. Int J Clin Pharmacol Ther 50:851–861PubMedGoogle Scholar
  58. 58.
    Emmerton L, Shaw J, Kheir N (2003) Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 28:395–402PubMedGoogle Scholar
  59. 59.
    Fejzic JB, Tett SE (2004) Medication management reviews for people from the former Yugoslavia now resident in Australia. Pharm World Sci 26:271–276PubMedGoogle Scholar
  60. 60.
    Hall DL, Pater KS (2011) Implementation of a medication therapy management program in a hospital-based outpatient pharmacy. Hosp Pharm 46:512–518Google Scholar
  61. 61.
    Kassam R, Farris KB, Burback L, Volume CI, Cox CE, Cave A (2001) Pharmaceutical care research and education project: pharmacists’ interventions. J Am Pharm Assoc 41:401–410Google Scholar
  62. 62.
    Krass I, Smith C (2000) Impact of medication regimen reviews performed by community pharmacists for ambulatory patients through liaison with general medical practitioners. Int J Pharm Pract 8:111–120Google Scholar
  63. 63.
    Krska J, Avery AJ (2007) Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol 65(3):386–396PubMedCentralPubMedGoogle Scholar
  64. 64.
    McDonough RP, Doucette WR (2003) Drug therapy management: an empirical report of drug therapy problems, pharmacists’ interventions, and results of pharmacists’ actions. J Am Pharm Assoc 43:511–518Google Scholar
  65. 65.
    Midlov P, Bondesson A, Eriksson T, Petersson J, Minthon L, Hoglund P (2002) Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson’s disease at nursing homes in southern Sweden. Eur J Clin Pharmacol 57:903–910PubMedGoogle Scholar
  66. 66.
    Roth MT, Esserman DA, Ivey JL, Weinberger M (2009) Racial disparities in the quality of medication use in older adults: baseline findings from a longitudinal study. J Gen Intern Med 25:228–234PubMedCentralPubMedGoogle Scholar
  67. 67.
    Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P (2006) Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 28:61–64PubMedGoogle Scholar
  68. 68.
    Westberg SM, Sorensen TD (2005) Pharmacy-related health disparities experienced by non-English-speaking patients: impact of pharmaceutical care. J Am Pharm Assoc 45:48–54Google Scholar
  69. 69.
    Al-Olah YH, Al Thiab KM (2008) Admissions through the emergency department due to drug-related problems. Ann Saudi Med 28426–429Google Scholar
  70. 70.
    Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM (2011) Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf 20:738–746PubMedGoogle Scholar
  71. 71.
    Blix HS, Viktil KK, Moger TA, Reikvam A (2006) Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 28:152–158PubMedGoogle Scholar
  72. 72.
    Khdour MR, Jarab AS, Adas HO, Samaro EZ, Mukattash TL, Hallak HO (2012) Identification of drug-related problems: a prospective study in two general hospitals. Curr Clin Pharmacol 7:276–281PubMedGoogle Scholar
  73. 73.
    Krahenbuhl J-M, Decollogny A, Bugnon O (2008) Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program. Pharm World Sci 30:816–822PubMedGoogle Scholar
  74. 74.
    Krahenbuhl J-M, Kremer B, Guignard B, Bugnon O (2008) Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci 30:777–786PubMedGoogle Scholar
  75. 75.
    Laaksonen R, Duggan C, Bates I (2010) Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother 44:1181–1190PubMedGoogle Scholar
  76. 76.
    Leikola S, Virolainen J, Tuomainen L, Tuominen RK, Airaksinen MSA (2012) Comprehensive medication reviews for elderly patients: findings and recommendations to physicians. J Am Pharm Assoc 52:630–633Google Scholar
  77. 77.
    Patel HR, Pruchnicki MC, Hall LE (2005) Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother 39:22–27PubMedGoogle Scholar
  78. 78.
    Ruths S, Straand J, Nygaard HA (2003) Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen district nursing home (BEDNURS) study. Qual Saf Health Care 12:176–180PubMedCentralPubMedGoogle Scholar
  79. 79.
    Somers A, Robays H, Vander Stichele R, Van Maele G, Bogaert M, Petrovic M (2010) Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging 14:477–482PubMedGoogle Scholar
  80. 80.
    van Roozendaal BW, Krass I (2009) Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharm World Sci 31:580–595PubMedCentralPubMedGoogle Scholar
  81. 81.
    Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP (2009) Pharmacist-based medication review reduces potential drug-related problems in the elderly. Drugs Aging 26:123–133PubMedGoogle Scholar
  82. 82.
    Finkers F, Maring JG, Boersma F, Taxis K (2007) A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther 32:469–476PubMedGoogle Scholar
  83. 83.
    Puts MTE, Cosat-Lima B, Monette J, Girre V, Wolfson C, Batist G, Bergman H (2009) Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study. Drugs Aging 26:519–536PubMedGoogle Scholar
  84. 84.
    Puts MTE, Monette J, Girre V, Cosat-Lima B, Wolfson C, Batist G, Bergman H (2010) Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment. Drugs Aging 27:559–572PubMedGoogle Scholar
  85. 85.
    Stafford L, Stafford A, Hughes J, Angley M, Bereznicki L, Peterson G (2011) Drug-related problems identified in post-discharge medication reviews for patients taking warfarin. Int J Clin Pharm 33:612–626Google Scholar
  86. 86.
    Stuijt CCM, Franssen EJF, Egberts ACG, Hudson SA (2008) Appropriateness of prescribing among elderly patients in a Dutch residential home. Drugs Aging 25:947–954PubMedGoogle Scholar
  87. 87.
    Taegtmeyer AB, Curkovic I, Rufibach K, Corti N, Battegay E, Kullak-Ublick GA (2011) Electronic prescribing increases uptake of clinical pharmacologists’ recommendations in the hospital setting. Br J Clin Pharmacol 72:958–964PubMedCentralPubMedGoogle Scholar
  88. 88.
    Titley-Lake C, Barber N (2000) Drug-related problems in the elders of the British Virgin Islands. Int J Pharm Pract 8:53–59Google Scholar
  89. 89.
    Koh Y, Kutty FBM, Li SC (2003) Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci 25:135–137PubMedGoogle Scholar
  90. 90.
    Koh Y, Kutty FBM, Li SC (2005) Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 1:39–48PubMedCentralPubMedGoogle Scholar
  91. 91.
    Kwint H-F, Faber A, Gussekloo J, Bouvy ML (2011) Effects of medication review on drug-related problems in patients using automated drug-dispensing systems. Drugs Aging 28(4):305–314PubMedGoogle Scholar
  92. 92.
    Moczygemba LR, Barner JC, Gabrillo ER (2012) Outcomes of a medicare part D telephone medication therapy management program. J Am Pharm Assoc 52:e144–e152Google Scholar
  93. 93.
    Montgomery AT, Kalvemark-Sporrong S, Tully P, Kettis-Lindblad A (2008) Follow-up of patients receiving a pharmaceutical care service in Sweden. J Clin Pharm Ther 33:653–662PubMedGoogle Scholar
  94. 94.
    Ong SW, Fernandes OA, Cesta A, Bajcar JM (2006) Drug-related problems on hospital admission: relationship to medication information transfer. Ann Pharmacother 40:408–413PubMedGoogle Scholar
  95. 95.
    Langebrake C, Hilgarth H (2010) Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci 32:194–199PubMedGoogle Scholar
  96. 96.
    Raybardhan S, Balen RM, Partovi N, Loewen PS, Liu G, Jewesson PJ (2005) Documenting drug-related problems with personal digital assistants in a multisite health system. Am J Health Syst Pharm 62:1782–1787PubMedGoogle Scholar
  97. 97.
    Rogers K, Tierney M, Singh A, McLean W (2003) Assessment of a seamless care prescription/discharge notes form. Can J Hosp Pharm 56:14–23Google Scholar
  98. 98.
    Roth MT, Ivey JL, Esserman DA, Crisp G, Kurz J, Weinberger M (2013) Individualised medication assessment and planning: optimizing medication use in older adults in the primary care setting. Pharmacotherapy 33:787–797PubMedGoogle Scholar
  99. 99.
    Roughead EE, Barratt JD, Gilbert AL (2004) Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 13:83–87PubMedGoogle Scholar
  100. 100.
    Scott DM, Dewey MW, Johnson TA, Kessler ML, Friesner DL (2010) Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota. Consult Pharm 25:305–319PubMedGoogle Scholar
  101. 101.
    Sorensen L, Stokes JA, Purdie DM, Woodward MC, Elliott RA, Roberts MS (2004) Medication reviews in the community: results of a randomised, controlled effectiveness trial. Br J Clin Pharmacol 58(6):648–664PubMedCentralPubMedGoogle Scholar
  102. 102.
    Sturgess IK, McElnay JC, Hughes CM, Crealey G (2003) Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 25:218–226PubMedGoogle Scholar
  103. 103.
    Vink J, Morton D, Ferreri S (2011) Pharmacist identification of medication-related problems in the home care setting. Consult Pharm 26:477–484PubMedGoogle Scholar
  104. 104.
    Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P (2001) Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 35:1343–1349PubMedGoogle Scholar
  105. 105.
    Hata M, Klotz R, Sylvies R, Hess K, Schwartzmann E, Scott J, Law AV (2012) Medication therapy management services provided by student pharmacists. Am J Pharm Educ 76 Article 51:1–6Google Scholar
  106. 106.
    Hooper R, Adam A, Kheir N (2009) Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar. Drug Health Patient Saf 1:73–80Google Scholar
  107. 107.
    Becker C, Bjornson DC, Kuhle JW (2004) Pharmacist care plans and documentation of follow-up before the Iowa pharmaceutical case management program. J Am Pharm Assoc 44:350–357Google Scholar
  108. 108.
    Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, Rasmussen M (2009) Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 31:216–223PubMedGoogle Scholar
  109. 109.
    Tenni P, Stafford A, Peterson G, Jackson SL (2007) A comparison of drug related problems identified in RMMRs and HMRs. Aust Pharm 26:414–420Google Scholar
  110. 110.
    Haugbolle LS, Sorensen EW (2006) Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma—interviewing patients at home. Pharm World Sci 28:239–247PubMedGoogle Scholar
  111. 111.
    Kaur S, Roberts JA, Roberts MS (2012) Evaluation of medication-related problems in medication reviews: a comparative perspective. Ann Pharmacother 46:972–982PubMedGoogle Scholar
  112. 112.
    Zaal RJ, Jansen MMPM, Duisenberg-van Essenberg M, Tijssen CC, Roukema JA, Van Den Bemt PMLA (2013) Identification of drug-related problems by a clinical pharmacist in addition to computerised alerts. Int J Clin Pharm 35:753–762PubMedGoogle Scholar
  113. 113.
    Garcao JA, Cabrita J (2002) Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc 42:858–864Google Scholar
  114. 114.
    Nurgat ZA, Al-Jazairi AS, Abu-Shraie N, Al-Jedai A (2011) Documenting clinical pharmacist intervention before and after the introduction of a web-based tool. Int J Clin Pharm 33:200–207PubMedGoogle Scholar
  115. 115.
    Eichenberger PM, Haschke M, Lampert ML, Hersberger KE (2011) Drug-related problems in diabetes and transplant patients: an observational study with home visits. Int J Clin Pharm 33:815–823PubMedGoogle Scholar
  116. 116.
    Ax F, Branstad J-O, Westerlund T (2010) Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther 35:439–451PubMedGoogle Scholar
  117. 117.
    Eickhoff C, Hammerlein A, Griese N, Schulz M (2012) Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf 21:254–260PubMedGoogle Scholar
  118. 118.
    Basheti IA, Qunaibi EA, Bulatova NR, Samara S, AbuRuz S (2013) Treatment related problems for outpatients with chronic diseases in Jordan: the value of home medication reviews. Int J Clin Pharm 35:92–100PubMedGoogle Scholar
  119. 119.
    Singh H, Kumar BN, Sinha T, Dulhani N (2011) The incidence and nature of drug-related hospital admission: a 6-month observational study in a tertiary health care hospital. J Pharmacol Pharmacother 2:17–20PubMedCentralPubMedGoogle Scholar
  120. 120.
    Van Mil JWF, Dudok van Heel MC, Boersma M, Tromp FJ (2001) Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Healt Syst Pharm 58:1428–1431Google Scholar
  121. 121.
    Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, Kilhovd B, Viktil KK, Horn AM (2010) Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci 32:394–403PubMedGoogle Scholar
  122. 122.
    Ellis SL, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sintek CD, Dombrowski R, Geraets DR, Amato M (2000) Types of interventions made by clinical pharmacists in the IMPROVE study. Pharmacotherapy 20:429–435PubMedGoogle Scholar
  123. 123.
    Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-Lindblad A, Melhus H, Morlin C (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med 169:894–900PubMedGoogle Scholar
  124. 124.
    Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA (2003) Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 163:1813–1820PubMedGoogle Scholar
  125. 125.
    Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ (2008) Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 48:203–211Google Scholar
  126. 126.
    LaFleur J, McBeth C, Gunning K, Oberda L, Steinvoort C, Oberda GM (2006) Prevalence of drug-related problems and cost-savings opportunities in Medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm 12:677–685PubMedGoogle Scholar
  127. 127.
    Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H (2009) Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomised, controlled study. Pharmacotherapy 29:1433–1440PubMedGoogle Scholar
  128. 128.
    Shimp LA, Kucukarslan SN, Elder J, Remington T, Wells T, Choe HM, Lewis NJW, Kirking DM (2012) Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs. J Am Pharm Assoc 52(768–776)Google Scholar
  129. 129.
    Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD (2002) Collaborative medication management services: improving patient care. Med J Aust 177:189–192PubMedGoogle Scholar
  130. 130.
    Kwint H-F, Gussekloo J, Bouvy ML (2012) The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther 37:674–680PubMedGoogle Scholar
  131. 131.
    Naunton M, Peterson GM (2003) Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital. J Pharm Pract Res 33:176–182Google Scholar
  132. 132.
    Stemer G, Laml-Wallner G, Kuegler I, Poelzleitner P, Messner S, Steininger S, Dolinar E, Zehetmayer S (2012) Comprehensive evaluation of clinical pharmacists’ interventions in a large Austrian tertiary care hospital. Eur J Hosp Pharm 19:529–534Google Scholar
  133. 133.
    Alderman CP, Farmer C (2001) A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract 21:99–103PubMedGoogle Scholar
  134. 134.
    Al-Hajje AH, Atoui F, Awada S, Rachidi S, Zein S, Salameh P (2012) Drug-related problems identified by clinical pharmacist’s students and pharmacist’s interventions. Ann Pharm Fr 70:169–176PubMedGoogle Scholar
  135. 135.
    Bednall R, McRobbie D, Hicks A (2003) Identification of medication-related attendances at an A and E department. J Clin Pharm Ther 28:41–45PubMedGoogle Scholar
  136. 136.
    Bedouch P, Charpiat B, Conort O, Rose F-X, Escofier L, Juste M, Roubille R, Allenet B (2008) Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother 42:1095–1103PubMedGoogle Scholar
  137. 137.
    Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF (2006) Drug-related problems in the community setting: pharmacists’ findings and recommendations for people with mental illnesses. Clin Drug Investig 26(7):415–425PubMedGoogle Scholar
  138. 138.
    Blix HS, Viktil KK, Reikvam A, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK (2004) The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 60:651–658PubMedGoogle Scholar
  139. 139.
    Bourne RS, Dorward BJ (2011) Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation. Int J Clin Pharm 33:755–758PubMedGoogle Scholar
  140. 140.
    Castelino RL, Bajorek BV, Chen TF (2011) Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Pract 17:104–110PubMedGoogle Scholar
  141. 141.
    Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA (2013) Drug-related visits to the emergency department in a Spanish university hospital. Int J Clin Pharm 35:727–735PubMedGoogle Scholar
  142. 142.
    Christensen DB, Roth MT, Trygstad T, Byrd J (2007) Evaluation of a pilot medication therapy management project within the North Carolina state health plan. J Am Pharm Assoc 47:471–483Google Scholar
  143. 143.
    Davidsson M, Vibe OE, Ruths S, Blix HS (2011) A multidisciplinary approach to improve drug therapy in nursing homes. J Multidiscip Healthc 4:9–13PubMedCentralPubMedGoogle Scholar
  144. 144.
    de Oliveira DR, Brummel AR, Miller DB (2010) Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 16:185–195Google Scholar
  145. 145.
    Ellitt GR, Engblom E, Aslani P, Westerlund T, Chen TF (2010) Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci 32:622–630PubMedGoogle Scholar
  146. 146.
    Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, Fries DJ, Kuhle CL (2004) Population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program. Ann Pharmacother 38:1823–1829PubMedGoogle Scholar
  147. 147.
    Freeman CR, Cottrell WN, Kyle G, Williams ID, Nissen L (2013) An evaluation of medication review reports across different settings. Int J Clin Pharm 35:5–13PubMedGoogle Scholar
  148. 148.
    Hugtenburg JG, Blom ATG, Gopie CTW, Beckeringh JJ (2004) Communicating with patients the second time they present their prescription at the pharmacy. Pharm World Sci 2004(26):328–332Google Scholar
  149. 149.
    Lee J, McPherson ML (2006) Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm 63:2235–2239PubMedGoogle Scholar
  150. 150.
    Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG (2010) Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf 19:141–149PubMedGoogle Scholar
  151. 151.
    Lopez MAP, Saliente MTA, Company ES, Monsalve AG, Cueva MA, Domingo EA, Hernandez MM, Carrion CC, Marti MC, Querejeta NB, Blasco JB, Mila AR (2010) Drug-related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS. Int J Pharm Pract 18:297–304PubMedGoogle Scholar
  152. 152.
    Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS (2003) Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy 23:231–239PubMedGoogle Scholar
  153. 153.
    Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS (2003) Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 41:386–393PubMedGoogle Scholar
  154. 154.
    Manley HJ, Drayer DK, Muther RS (2003) Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrology 4:http://www.biomedcentral.com/1471-2369/1474/1410
  155. 155.
    Mannheimer B, Ulfvarson J, Eklof S, Bergqvist M, Andersen-Karlsson E, Pettersson H, von Bahr C (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62:1075–1081PubMedGoogle Scholar
  156. 156.
    Maxwell K, Harrison J, Scahill S, Braund R (2013) Identifying drug-related problems during transition between secondary and primary care in New Zealand. Int J Pharm Pract 21:333–336PubMedGoogle Scholar
  157. 157.
    Milos V, Rekman E, Bondesson A, Eriksson T, Jakobsson U, Westerlund T, Midlov P (2013) Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled trial. Drugs Aging 30:235–246PubMedGoogle Scholar
  158. 158.
    Pai AB, Boyd A, Chavez A, Manley HJ (2009) Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomised, controlled study. Hemodial Int 13:72–79PubMedGoogle Scholar
  159. 159.
    Parthasarathi G, Ramesh M, Kumar JK, Madaki S (2003) Assessment of drug-related problems and clinical pharmacists’ interventions in an Indian teaching hospital. J Pharm Pract Res 33:272–274Google Scholar
  160. 160.
    Rao D, Gilbert AL, Strand LM, Cipolle RJ (2007) Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci 29:647–654PubMedGoogle Scholar
  161. 161.
    Repp KL, Hayes C, Woods M, Allen KB, Kennedy K, Borkon MA (2012) Drug-related problems and hospital admissions in cardiac transplant recipients. Ann Pharmacother 46:1299–1307PubMedGoogle Scholar
  162. 162.
    Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, Goeree R, Cosby R, Trim K, Sebalt R, Howard M, Hardcastle L, Poston J (2003) A randomised controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 169:17–22PubMedCentralPubMedGoogle Scholar
  163. 163.
    Taegtmeyer AB, Curkovic I, Corti N, Rosen A, Egbring M, Russmann S, Gantenbein AR, Weller M, Kullak-Ublick GA (2012) Drug-related problems and factors influencing acceptance of clinical pharmacologists’ alerts in a large cohort of neurology inpatients. Swiss Med Wkly 142:w13615PubMedGoogle Scholar
  164. 164.
    Touchette DR, Massica AL, Dolor RJ, Schumock GT, Choi YK, Kinm Y, Smith SR (2012) Safety-focused medication therapy management: a randomized controlled trial. J Am Pharm Assoc 52:603–612Google Scholar
  165. 165.
    Viktil KK, Blix HS, Reikvam A, Moger TA, Hjemaas BJ, Walseth EK, Vraalsen TF, Pretsch P, Jorgensen F (2004) Comparison of drug-related problems in different patient groups. Ann Pharmacother 38:942–948PubMedGoogle Scholar
  166. 166.
    Viktil KK, Blix HS, Moger TA, Reikvam A (2006) Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 15:667–674PubMedGoogle Scholar
  167. 167.
    Westerlund T, Gelin U, Pettersson E, Skarlund F, Wagstrom K, Ringbom C (2013) A retrospective analysis of drug-related problems documented in a national database. Int J Clin Pharm 35:202–209PubMedGoogle Scholar
  168. 168.
    Schaefer M (2002) Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 24:120–127PubMedGoogle Scholar
  169. 169.
    Brulhart MI, Wermeille JP (2011) Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 33:549–557PubMedGoogle Scholar
  170. 170.
    Joseph J, Ramesh M, Harugeri A, Parthasarathi G, Basavanagowdappa H (2010) Frequency and nature of medication-related problems in elderly Indian inpatients. J Pharm Pract Res 40:279–283Google Scholar
  171. 171.
    Elliott RA, Martinac G, Campbell S, Thorn J, Woodward MC (2012) Pharmacist-led medication review to identify medication-related problems in older people referred to an aged care assessment team. A randomized comparative study. Drugs Aging 29(7):593–605PubMedGoogle Scholar
  172. 172.
    Easton KL, Chapman CB, Brien JE (2004) Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 57:611–615PubMedCentralPubMedGoogle Scholar
  173. 173.
    Gisev N, Bell JS, O'Reilly CL, Rosen A, Chen TF (2010) An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Soc Psychiatr Epidemiol 45:1071–1079Google Scholar
  174. 174.
    Ernst ME, Doucette WR, Dedhiya SD, Osterhaus MC, Kumbera PA, Osterhaus JT, Townsend RJ (2001) Use of point-of-sale health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy 21:988–997PubMedGoogle Scholar
  175. 175.
    Ulfvarson J, Rahmner PB, Fastbom J, Sjoviker S, Karlsson EA (2010) Medication reviews with computerised expert support. Evaluation of a method to improve the quality of drug utilisation in the elderly. Int J Health Care Qual Assur 23:571–582PubMedGoogle Scholar
  176. 176.
    Bergqvist M, Ulfvarson J, Karlsson EA (2009) Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients. Eur J Clin Pharmacol 65:1089–1096PubMedGoogle Scholar
  177. 177.
    Celin AT, Seuma J, Ramesh A (2012) Assessment of drug-related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Ind J Pharm Pract 5:28–33Google Scholar
  178. 178.
    Charpiat B, Goutelle S, Schoeffler M, Aubrun F, Viale J-P, Ducerf C, Leboucher G, Allenet B (2012) Prescriptions analysis by clinical pharmacists in the post-operative period: a 4-year prospective study. Acta Anaesthesiol Scand 56:1047–1051PubMedGoogle Scholar
  179. 179.
    Delate T, Chester EA, Stubbings TW, Barnes CA (2008) Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility. Pharmacotherapy 28:444–452PubMedGoogle Scholar
  180. 180.
    Doucette WR, McDonough RP, Klepser D, McCarthy R (2005) Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 27:1104–1111PubMedGoogle Scholar
  181. 181.
    Martinez-Lopez I, Do-Pazo-Oubina F, Lozano-Vilardell P (2011) Comprehensive pharmaceutical care in a vascular surgery department. Farm Hosp 35:260–263PubMedGoogle Scholar
  182. 182.
    Prot-Labarthe S, Di Paolo ER, Lavoie A, Quennery S, Bussieres J-F, Brion F, Bourdon O (2013) Pediatric drug-related problems: a multicenter study in four French-speaking countries. Int J Clin Pharm 35:251–259PubMedGoogle Scholar
  183. 183.
    Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW (2006) Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 166:565–571PubMedGoogle Scholar
  184. 184.
    Triller DM, Clause SL, Briceland LL, Hamilton RA (2003) Resolution of drug-related problems in home care patients through a pharmacy referral service. Am J Health Syst Pharm 60:905–910PubMedGoogle Scholar
  185. 185.
    Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D (2000) Providing pharmaceutical care using a systematic approach. Pharm J 265:656–660Google Scholar
  186. 186.
    Wermeille J, Bennie M, Brown I, McKnight J (2004) Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci 26:18–25PubMedGoogle Scholar
  187. 187.
    Vercaigne LM, Grymonpre RE, Metge C, Sekyere J, Cooper R (2000) Manitoba pharmaceutical care project; interim report. Can Pharm J 133:1–7Google Scholar
  188. 188.
    Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A (2011) Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Cardiac Fail 17:217–223Google Scholar
  189. 189.
    Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD (1990) Drug-related problems: their structure and function. Drug Intell Clin Pharm (Ann Pharmacother) 24:1093–1097Google Scholar
  190. 190.
    Castelino RL, Sathvik BS, Parthasarathi G, Gurudev KC, Shetty MS, Narahari MG (2011) Prevalence of medication-related problems among patients with renal compromise in an Indian hospital. J Clin Pharm Ther 36:481–487PubMedGoogle Scholar
  191. 191.
    Rossing C, Hansen EH, Krass I, Traulsen JM (2003) Pharmaceutical care in Denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharm World Sci 25:73–78PubMedGoogle Scholar
  192. 192.
    Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M, Kressig RW, Kraehenbuehl S, Bingisser R (2013) Drug-related emergency department visits by elderly patients presenting with non-specific complaints. http://www.sjtrem.com/content/21/1/15 SJTREM 21:1–9
  193. 193.
    Chan D-C, Chen J-H, Wen C-J, Chiu L-S, Wu S-C (2012) Effectiveness of the medication safety review clinics for older adults prescribed multiple medications. J Formos Med Assoc. doi: 10.1016/j.jfma.2012.04.013 Google Scholar
  194. 194.
    Smith M, Giuliano MR, Starkowski MP (2011) In Connecticut: improving patient medication management in primary care. Health Aff 30:646–654Google Scholar
  195. 195.
    Rogers S, Wilson DA, Wan S, Griffin M, Rai G, Farrell J (2009) Medication-related admissions in older people. A cross-sectional, observational study. Drugs Aging 26:951–961PubMedGoogle Scholar
  196. 196.
    de Oliveira MPF, Novaes MRCG (2011) Drug-related problems in institutionalised elderly in Brasilia, Brazil. Biomed Aging Pathol 1:179–184Google Scholar
  197. 197.
    Viktil KK, Blix HS, Moger TA, Reikvam A (2006) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63:187–195PubMedCentralPubMedGoogle Scholar
  198. 198.
    Zed PJ, Riyad B, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur K, Weins MO, Samoy LJ, Lacaria K, Purssell RA (2008) Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 178:1563–1569PubMedCentralPubMedGoogle Scholar
  199. 199.
    Westerlund T, Marklund B (2009) Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther 34:319–327PubMedGoogle Scholar
  200. 200.
    Willoch K, Blix HS, Pederson-Bjergaard AM, Eek AK, Reikvam A (2012) Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm 34:382–388PubMedGoogle Scholar
  201. 201.
    Pintor-Marmol A, Baena MI, Fajardo PC, Sabater-Hernandez D, Saez-Benito L, Garcia-Cardenas MV, Fikri-Benbrahim N, Azpilicueta I, Faus MJ (2012) Terms used in patient safety related to medication: a literature review. Pharmacoepidemiol Drug Saf 21:799–809PubMedGoogle Scholar
  202. 202.
    Fernandez-Llimos F, Faus MJ (2005) From “drug-related problems” to “negative clinical outcomes”. Am J Health Syst Pharm 62:2348–2350PubMedGoogle Scholar
  203. 203.
    Andreazza RS, De Castro MS, Koche PS, Heineck I (2011) Causes of drug-related problems in the emergency room of a hospital in southern Brazil. Gac Sanit 25:501–506PubMedGoogle Scholar
  204. 204.
    Hatah E, Tordoff J, Duffull SB, Braund R (2014) Pharmacists’ performance of clinical interventions during adherence support medication reviews. RSAP 10:185–194PubMedGoogle Scholar
  205. 205.
    Villa LA, Von Chrismar AM, Oyarzun C, Eujenin P, Fernandez ME, Quezada M (2009) Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes. Lat Am J Pharm 28:415–420Google Scholar
  206. 206.
    Rashed AS, Neubert A, Alhamdan H, Tomlin S, Alazmi A, Al Shaikh A, Wilton L, Wong ICK (2013) Drug-related problems found in children attending an emergency department in Saudi Arabia and in the United Kingdom. Int J Clin Pharm 35:327–331PubMedGoogle Scholar
  207. 207.
    Cipolle RJ, Strand LM, Morley PC (2004) Pharmaceutical care practice: the clinician’s guide 2nd edition. McGraw-HillGoogle Scholar
  208. 208.
    Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-kholi TA, Akhras NS, Horanieh BK (2008) The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Med J 29:277–281PubMedGoogle Scholar
  209. 209.
    de Almeida NY, da Silva CW, de Assis AF (2009) Drug-related problems observed in a pharmaceutical care service, Belo Horizonte, Brazil. Braz J Pharm Sci 45:321–330Google Scholar
  210. 210.
    Krska J, Ross SM, Watts M (2005) Medication reviews provided by general medical practitioners (GPs) and nurses: an evaluation of their quality. Int J Pharm Pract 13:77–84Google Scholar
  211. 211.
    Mirkov SR, Ball PA (2003) Design and pilot of a medication review clinic in a dialysis centre. J Pharm Pract Res 33:199–203Google Scholar
  212. 212.
    Gisev N, Bell JS, Chen TF (2013) Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Soc Adm Pharm 9:330–338Google Scholar
  213. 213.
    Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B, Juste M, Conort O (2006) Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci 28:181–188PubMedGoogle Scholar
  214. 214.
    Tujn S, Janssens F, Robben P, van den Bergh H (2012) Reducing interrater variability and improving health care: a meta-analytical review. J Eval Clin Pract 18:887–895Google Scholar
  215. 215.
    Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F (2013) A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother 47:946–952PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Benjamin J. Basger
    • 1
    Email author
  • Rebekah J. Moles
    • 1
  • Timothy F. Chen
    • 1
  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia

Personalised recommendations